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Background/aim: Accurate measurement of glomerular filtration rate (GFR) in the evaluation of renal functions in potential kidney
donors is associated with important outcomes for both the donor and recipient. We intended to determine the efficacy of various
methods while estimating GFR in potential living kidney donors.
Materials and methods: Fifty-three potential kidney donors (31 females, 22 males; mean age: 50.1 years) were included in this study.
GFR was estimated simultaneously using the following methods: Gates’ method, Cockcroft–Gault (CG) and modification of diet in
renal disease (MDRD) prediction equations, and the two-plasma sample (TPS) technique. Using TPS as the reference method, the
estimations of GFR with the other methods were compared with that of TPS.
Results: The mean ± SD GFR was 86.43 ± 11.37 mL min–1 1.73 m–2 with TPS. GFR values calculated using Gates’ method and MDRD 1,
MDRD 2, reexpressed MDRD, and CG prediction equations were 105.25 ± 16.12 mL min–1 1.73 m–2, 114.63 ± 32.51 mL min–1 1.73 m–2,
113.2 ± 35.23 mL min–1 1.73 m–2, 104.23 ± 23.12 mL min–1 1.73 m–2, and 99.35 ± 20.01 mL min–1 1.73 m–2, respectively. While there was
a strong statistically significant correlation between the TPS and Gates’ methods, moderate correlation was found between TPS and the
MDRD 1, MDRD 2, and reexpressed MDRD prediction equations.
Conclusion: Our results indicated that the performance of Gates’ method in total GFR estimation was better than the prediction
equations in potential kidney donors.
Key words: Glomerular filtration rate, kidney donors, two-plasma sample

1. Introduction
Assessment of renal function and morphology in potential
kidney donors is crucial (1). The renal function of the
donor has important long-term consequences for both the
donor and the recipient. Recipients have double the risk
of graft loss when receiving a kidney from a live donor
with a glomerular filtration rate (GFR) of <80 mL/min (2).
Most transplant centers exclude potential donors with a
creatinine clearance under 80 mL/min (3).
GFR is considered the best index of overall kidney
function (4,5). GFR can be determined by measuring renal
clearance of an intrinsic or extrinsic agent that is freely
filtered by the glomeruli (6,7). Inulin clearance has been
widely believed to be the gold standard for GFR studies, but
it is relatively invasive and not easy to perform in everyday
practice (8). Measurement of Tc-99m diethylenetriamine
* Correspondence: ayankursad@gmail.com

pentaacetic acid (Tc-99m DTPA) plasma clearance is
used by many institutions for the determination of total
GFR due to its simplicity and precision (9–12). It is also
reported that there is a correlation between Tc-99m DTPA
and inulin clearances when measuring GFR in clinical
applications (13).
Measured Tc-99m DTPA serum clearance by multipleplasma sample method (MPSM) is similar to inulin
clearance; however, it is not practical to collect multiple
plasma samples on a daily routine (14). To facilitate the
procedure, Tc-99m DTPA clearance by the two-plasma
sample (TPS) method was compared to MPSM and a
significant correlation was reported (15). Serum creatinine
is also a clinically useful marker for evaluating kidney
functions. It is widely available and easy and inexpensive to
use, but estimated GFR based on serum creatinine is likely
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to be inaccurate (16). To remedy this shortcoming, several
formulas have been developed for precise calculation
of GFR. The Cockcroft–Gault (CG) equation and the
modification of diet in renal disease (MDRD) formulas
have been offered in clinical guidelines for the calculation
of GFR (17). The gamma camera Gates’ method has also
been utilized for the prediction of GFR, but the accuracy
of this method is controversial (18,19).
Regarding TPS as a reference, we intended to determine
the efficacy of Gates’ method, MDRD methods, and CG
formulas while estimating GFR in potential living kidney
donors.
2. Materials and methods
2.1. Subjects
This study involved 53 potential kidney donors. Donors
comprise 31 females and 22 males (age range: 25 to 70
years; median age: 51 years; mean age: 50.1 ± 10.6 years).
We collected data on age, sex, weight, height, body surface
area, blood urea nitrogen (BUN), serum creatinine
(SCr), and serum albumin from each subject. The ethics
committee of our university approved this study.
2.2. Measurement of glomerular filtration rate
We normalized all GFR values to 1.73 m2 of body surface
area.
2.2.1. Determination of GFR with Gates’ method (18–20)
TPS and Gates methods were carried out simultaneously.
DTPA was reconstituted in our department using
a commercially available kit (TechneScan DTPA,
Mallincrodt Medical B.V, Petten, the Netherlands).
Radiochemical quality control was performed with thinlayer paper chromatography (ITLCTM, SG, Gelman
Sciences, Ann Arbor, MI, USA) prior to each study. The
fractions of Tc-99m (as free pertechnetate) and Tc-99m
DTPA were determined by using methyl ethyl ketone and
saline (0.9% NaCl) for unchelated hydrolyzed reduced Tc99m as the eluent. The overall labeling efficiency was 96.4
± 0.5% (mean ± SD) and Tc-99m DTPA was not used if
the labeling efficiency was below 95%. After reconstitution
and quality control of the radiopharmaceutical, two equal
doses of 148 MBq of Tc-99m DTPA were prepared as the
standard and the patient dose.
All patients were hydrated orally with 500 mL of
water 30 min prior to injection. Oral fluid hydration was
continued at 300–500 mL h–1 during the entire study
until blood sampling at 240 min. The study was initiated
simultaneously with the intravenous injection of 4 mCi
(148 MBq) of Tc-99m DTPA. The patient was placed
in the supine position and a dose of furosemide, with a
maximum dose of 40 mg, was administered. Furosemide
was used routinely in all patients. The dynamic
image acquisition was performed for 30 min with a singlehead gamma camera with a parallel-hole, low-energy,
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high-resolution collimator (GE-Starcam 4000 XR/T, St
Albans, Hertfordshire, UK). Individual and total GFRs
were readily obtained using Gates’ method.
The GFR values were determined 2–3 min after
injection of the Tc-99m DTPA. Renal and crescent-shaped
background inferior regions of interest (ROIs) were drawn
manually.
2.2.2. Determination of GFR with the TPS method
(21,22)
After IV injection of Tc-99m DTPA, blood samples were
taken from the contralateral arm into EDTA anticoagulant
tubes and subjected immediately to centrifugation at
2000 rpm for 10 min. Plasma samples (1 mL) and the
standards were counted in a gamma counter (Atomlab 950
LPC, Biodex Medical, Shirley, NY, USA) for 1 min. Blood
samples were taken at 120 min and 240 min and used for
the TPS.
GFR was calculated in mL min–1 as follows:
GFR (ml/min) =

Dln (P1 /P2)
(T1 lnP2) - (T2 lnP1)
exp
T2 - T1
T2 - T1

where D = dose activity (cpm); T1 = 120 min; T2 = 240 min;
P1 = activity at T1; P2 = activity at T2; and P1 and P2 are in
counts min–1 mL–1.
2.2.3. Estimation of GFR by prediction equations (9,23)
MDRD 1:
-0.999
-0.176
-0.176
GFR = 170 # S c
#A
# (BUN)
#
(Albumin)

-0.318

(#0.762 for female patients)

MDRD 2:
-1.154

GFR = 186 # S c

#A

-0.203

(#0.742 for female patients)

where Sc = serum creatinine (mg dL–1) and A = age (in
years).
Standardization of serum creatinine in donors:
This is used to standardize SCr measurements between
different centers to minimize variability (24,25). It is also
reported to calculate the reexpressed MDRD equation by
standardizing the SCr values with the following formula:
Cleveland Clinic (CCF) standardized SCr = 0.906 ×
(0.099 + 0.981 × Sc)
The new reexpressed MDRD equation used herein was
as follows:
Reexpressed MDRD equation (24):
-1.154
-0.203
GFR = 175 # standardized S c # A
(#0.742 for female patients)
Cockcroft–Gault (26):
For man, the GFR im ml/min, is determined
(140 - A) # w
(140 - A) # w
by:
and for women, by:
S c # 72
S c # 72 # 0.85
Whenew=weight (kG)
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2.3. Statistical analyses
We used Pearson’s correlation coefficient for calibrating
the association between TPS and other methods (Gates’,
creatinine clearance, and prediction equations). Statistical
significance was defined as P < 0.05. The statistical
analyses were performed using SPSS (SPSS Inc., Chicago,
IL, USA). Bland–Altman analysis was performed to show
the difference between TPS and the other methods by the
mean of the two measures ± 2 SD.
3.Results
The mean age of the donors was 50.1 years. There were
31 (58%) women in the study group. The mean serum
creatinine was 0.7 ± 0.2 mg dL–1 (range: 0.4–1.3 mg dL–1).
The mean GFR was 86.43 mL min–1 1.73 m–2 (range: 35.99–
122.35 mL min–1 1.73 m–2) in the TPS method. The mean
± SD, minimum, maximum, and median GFR values in
the TPS method as well as the Gates’, MDRD 1, MDRD
2, reexpressed MDRD, and CG methods are presented in
Table 1.
Bland–Altman plots comparing TPS and the other
methods are shown in Figures 1–5. Assessment of the
performance of the Gates’ method and other prediction
equations are shown in Tables 1 and 2.
We found there was a strong correlation between the
TPS and Gates’ methods (r = 0.76, P = 0.0001). There was
also a moderate correlation between TPS and MDRD 1
(r = 0.47, P = 0.007), MDRD 2 (r = 0.38, P = 0.03), and
reexpressed MDRD (r = 0.57, P = 0.002). However, there
was no significant correlation between the TPS and CG
prediction equations. The correlation coefficient was r =
0.26, P = 0.16.
4. Discussion
Most transplant centers exclude potential donors with a
creatinine clearance under 80 mL min–1 (3). Creatinine
clearance has been used for many decades to estimate
GFR (26). In estimating GFR, inulin is the gold standard
method. There is a good correlation between Tc-99m
DTPA and inulin clearance for GFR measurement, so
it is commonly used to measure GFR (27,28). Tc-99m

DTPA is excreted by the kidney and it binds to plasma
proteins in the range of 5%–10%, which explains the
underestimation of the GFR in comparison with inulin,
which filters freely (29). Results MPSMs for the estimation
of GFR after a single Tc-99m DTPA injection have been
reported to be identical to inulin clearance (30). The
multiple blood sampling method’s correlation with the
dual blood sampling method is also well documented. TPS
was reported to be more precise in estimating GFR when
compared to the single plasma sample method (31) and it
was used in our study as the reference GFR (22).
Gamma camera-based clearance techniques for
GFR estimation are easy and convenient for clinical
use. Gates developed a method to estimate GFR,
the Gates’ method, in 1982 (18,32). This method is
very simple and suitable for predicting the GFR of any
differential renal function (33). However, there is also
some debate whether the Gates’ method is proper for
determining the GFR (34,35). Aydın et al. reported that the
Gates’ method is weakly correlated with the TPS method
(36). Nevertheless, Assadi et al. revealed that the Gates’
method has a good correlation with the plasma sample
method and was more precise than the CG method (37).
Our results are consistent with previous results (35). We
found a strong correlation between the TPS method and
Gates’ methods in our study.
There have been a number of formulas illustrating
GFR calculations by using biometrical parameters such as
height, weight, age, and sex, as well as calculations with
serum creatinine levels and other biochemical variables.
Among the commonly used equations are the CG and
MDRD equations. Whether these equations precisely
estimate the GFR or not has been disputed (38). While both
formulas have a lower accuracy in high GFR populations,
GFR predictions are less accurate in predicting GFR
values in healthy populations (39). The CG equation is
proclaimed to be better than the MDRD equation in the
prediction of GFR (40,41), though others have noted that
MDRD equations were better when compared to the CG
equation in kidney donors (26,27,30). Issa et al. showed
that the MDRD and reexpressed MDRD equations

Table 1. Assessment of the Gates’s method and other prediction equations.
Method

Mean

SD

Minimum

Maximum

Median

Median absolute ifference
(mL min–1 1.73 m–2)

Mean percentage
error

Gates

105.25

16.12

76.28

138.63

102.4

11.2

35.2 ± 16.2

MDRD1

114.63

32.51

66.22

196.24

111.24

20.3

46.6 ± 39.3

MDRD2

113.2

35.23

59.33

20287

109.82

18.1

45.5 ± 41.6

Reexpressed MDRD

104.23

23.12

67.75

152.74

102.13

12.9

34.6 ± 26.3

CG

99.35

20.01

62.25

148.23

98.24

3.7

24.6 ± 16..3
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Figure 1. Bland–Altman plot of two-plasma sample method versus gamma-camera Gates’ method.

Figure 2. Bland–Altman plot of two-plasma sample method versus MDRD 1.
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Figure 3. Bland–Altman plot of two-plasma sample method versus MDRD 2.

Figure 4. Bland–Altman plot of two-plasma sample method versus Reexp MDRD.
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Figure 5. Bland–Altman plot of two-plasma sample method versus Cockcroft–Gault.
Table 2. The comparison and regression analysis of GFR
measurement methods.
Method

R

R2

P

Gates

0.76

0.58

0.0001

MDRD 1

0.47

0.22

0.007

MDRD 2

0.38

0.14

0.03

Reexpressed MDRD

0.57

0.32

0.002

CG

0.26

0,07

0.16

underestimated GFR (22). The correlation among the
TPS and MDRD 1, MDRD 2, and reexpressed MDRD
prediction equations were moderate in our study. There
was no statistically significant correlation between TPS
and CG prediction equations.
We acknowledge some limitations. First, very few
individuals were included. Second, these analyses were
performed with a small sample size with wide variability in
clinical and laboratory parameters. Third, SCr, BUN, and
albumin measurements were not performed at the same
time in the same laboratory.
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In conclusion, the present study has investigated
several methods and compared the results with the TPS
considered as the reference. Among them, our results
demonstrate that Gates’ method can reflect GFR more
accurately than the other methods in potential kidney
donors. Further studies with large numbers of donor are
required to derive an improved prediction equation for
estimating GFR in donor populations.
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